Medical Developments International Limited Medical Developments International Limited

Medical Developments International Limited

MVP

Classifica tra le azioni #27357
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Prezzo delle azioni
$0.28211392
Capitalizzazione di mercato
$31.78M
Variazione (1 giorno)
1.27%
Variazione (1 anno)
-12.00%
Paese
AU
Scambia Medical Developments International Limited (MVP)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Medical Developments International Limited (MVP)
L’azione Medical Developments International Limited (simbolo: MVP) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 20, 2026.
Una quota di MVP acquistata prima di Oct 20, 2026 equivale oggi a 0 quote di MVP.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti